Adults 2 Months to 12 Months, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The Rating by the Primary Caregivers on the Use and Relevance of the Cry and Fuss Clock Generated From the LENA Recorder Data and the Rating by the Primary Caregiver on the Level of Engagement Due to the Content on the COOL Mobile App.Primary· 2 weeks
Rating by the primary caregiver about the usability and relevance using a 6-point scale \[0=Not at all, 5=Yes, very much\]; Scale 1 to 4 is subjective to user definition (not defined specifically)
Use and relevance scale 0 - Not at all
Group
Value
95% CI
LENA
3
Use and relevance Scale 1
Group
Value
95% CI
LENA
1
Use and relevance Scale 2
Group
Value
95% CI
LENA
3
Use and relevance Scale 3
Group
Value
95% CI
LENA
6
Use and relevance Scale 4
Group
Value
95% CI
LENA
7
Use and relevance Scale 5 - Yes, very much
Group
Value
95% CI
LENA
0
The Rating by the HCPs on the Use and Relevance of Data Provided by the LENA Recorder in Their General Practice.Secondary· 2 weeks
Rating by the HCP about the use and relevance of the LENA data in general practice using 6 point scale \[0=Not at all, 5=Yes, very much\], Scale 1 to 4 is subjective to user definition (not defined specifically)
Group
Value
95% CI
LENA
0
LENA
0
LENA
6
LENA
6
Exploratory Parameter :Total Crying and Fussing Time Captured by the LENA RecorderSecondary· 2 weeks
Exploratory Parameter : Total daily crying and fussing time captured by the LENA recorder in minutes
Group
Value
95% CI
LENA
19.6
± 30.7
Exploratory Parameter :Crying and Fussing Time Perceived by the ParentsSecondary· 2 weeks
Daily duration of cry and/or fuss in the scale of :
\<30 mins 30 mins to 1hr \>1hr to 3hrs \> 3hrs
< 30 mins
Group
Value
95% CI
LENA
105
30 mins to 1hr
Group
Value
95% CI
LENA
86
>1hr to 3hrs
Group
Value
95% CI
LENA
82
>3hrs
Group
Value
95% CI
LENA
16
Missing
Group
Value
95% CI
LENA
11
Usage Time of the Cocoon Cam App by the Primary CaregiverSecondary· 2 weeks
Usage time (in minutes) of the Cocoon Cam app by the primary caregiver.
Group
Value
95% CI
LENA
4.1
0 – 14.4
To Explore the Usability of Cocoon Cam and Data Captured by the Cocoon Cam App for the HCP in Their Daily PracticeSecondary· 2 weeks
To explore the usability of Cocoon Cam and data captured by the Cocoon Cam app for the HCP in their daily practice. Scale 0 = Not at all, Scale 5 = Yes very much. Scale 1 to 4 is subjective to user definition (not defined specifically)
Group
Value
95% CI
LENA
1
LENA
0
LENA
2
LENA
2
Sponsor's own description
Primary: The rating by the primary caregivers on the use and relevance of data provided by the Language ENvironment Analysis (LENA) recorder and their level of engagement due to the content on the Cool mobile app.
Secondary: The rating by the Healthcare Professionals (HCPs) on the use and relevance of data provided by the LENA recorder in their general practice
Exploratory
* Total crying and fussing time captured by the LENA recorder
* Crying and fussing time perceived by the parents
* Vital parameters like heart rate, sleep recorded by the Fitbit used by the primary caregiver during crying and fussing events registered by LENA
* Comments and feedback provided by the primary caregiver on the LENA recorder and the Cool mobile app
* Comments and feedback provided by the HCP on the LENA recorder and the data provided.
* Sleep time recorded by the Cocoon Cam
* Crying time recorded by the Cocoon Cam
* Crying start and end time recorded by the primary caregiver in the COOL app
* Sleep start and end time recorded by the primary caregiver in the COOL app
* Comments and feedback provided by the primary caregiver and HCP on the Cocoon Cam and the activity log for infant cry and sleep including push notifications in the Cocoon Cam app
* Usage data from the Cocoon Cam app
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other Danone Asia Pacific Holdings Pte, Ltd. trials
Trials by the same sponsor.
NCT07186205 — A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Risk of Iron Deficiency and A
· completed
NCT06577727 — A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children
· completed
NCT06578338 — Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children
· completed
NCT06578351 — TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
· completed
NCT05847543 — Building an AI to Infer/Predict an Estimated Stool Microbiome Profile
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danone Asia Pacific Holdings Pte, Ltd.
Last refreshed: 8 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03729960.